Jihui Hao    Professor

Pancreas Center, Tianjin Medical University Cancer Institute and Hospital; President of Tianjin Medical University Cancer Institute and Hospital; President of Tianjin Medical University

Address:

Huan Hu Xi Road, Ti Yuan Bei, He Xi District,  Tianjin 300060, P.R. China

Research Areas:

    Pancreatic cancer

Contact Info:

haojihui@tjmuch.com

+86-22-23340123-3022

Background

1.2020- present Professor, President, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

2.2010-2020  Professor, Vice President, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

3.2009-2010   Professor, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

4.2004-2009  Associate Professor, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

5.2002-2004  Post-doctoral fellowship, Department of Oncology, Queen Mary College, University of London, UK.

6.2001-2004  Attending Surgeon, Department of Abdominal Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

7.1995-2001  Resident Surgeon, Department of Abdominal Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

8.1997-2002  Ph.D. in Oncology, Department of Abdominal Surgery, Tianjin Medical University Cancer Hospital, Tianjin Medical University, Tianjin, China.

9.1990-1995    B.S. in Medicine, Department of Clinical Medicine, Tianjin Medical University, Tianjin, China.

Honors & Awards

1.2023 “Establishment and promotion of clinical diagnosis and treatment system for pancreatic cancer in Chinese population” was awarded the First Prize of Huaxia Medical Science and Technology Award

2.2023 “Study on the mechanism by which tumors reshape their microenvironment and drive their malignant progression” was awarded the Special Prize of Tianjin Science and Technology Progress by Tianjin Science Technology Committee

3.2022 “Establishment and clinical application of precision diagnosis and treatment system for pancreatic cancer” was awarded the First Prize of Science and Technology Progress Award of Ministry of Education

4.2018 “The Basis and Translation Research of Pancreatic Cancer Progression Driven by Hypoxic Microenvironment” was awarded the First Prize of the Chinese Anti-Cancer AssociationCACAScience and Technology Progress Award

5.2016 “Clinical and basic research on the establishment of precise diagnosis and treatment system for pancreatic cancer” was awarded the First Prize of Tianjin Science and Technology Progress by Tianjin Science Technology Committee.

6.2016 Young Scientist Award in Oncology of China

7.2009 “Effects of proteasome inhibitor on TRAIL-induced apoptosis in tumor cells” was awarded the Third Prize of Tianjin Science and Technology Progress  

8.2006 “Study on the mechanism of drug resistance on the apoptotic pathways and overcome strategies in blood malignancies” was awarded the Third Prize of Tianjin Nature and Science Award.

Other Roles

1.Vice chairman, Pancreatic Cancer Professional Committee, China Anti-Cancer Association

2.Vice chairman, Cancer Precision Treatment Professional Committee, China Anti-Cancer Association

3.Vice-chairman, Hepatobiliary and Pancreatic Surgery Professional Committee, China Medicine Education Association

4.Committee member, Pancreatic Surgery Group, Surgical Branch, Chinese Medical Association

5.Expert member, Oncology Subcommittee, Chinese Medical Association

6.Committee member, Professional Committee on Precision Medicine, Chinese Medical Doctor Association

7. Standing committee, Pancreatic Cancer Expert Committee, CSCO

8.Chairman, Pancreatic Cancer Professional Committee, Tianjin Anti-Cancer Association

9.Vice chairman, Tianjin Youth Federation

10.Editorial Services: Executive Editor-in-Chief of Cancer Biology & Medicine

11.Ad hoc reviews: Cancer Res.; J. Biol. Chem.; Signal Transduct Target Ther.; Cancer Letters; Int. J. Cancer; PLoS ONE.

Publications

1.Vice chairman, Pancreatic Cancer Professional Committee, China Anti-Cancer Association

2.Vice chairman, Cancer Precision Treatment Professional Committee, China Anti-Cancer Association

3.Vice-chairman, Hepatobiliary and Pancreatic Surgery Professional Committee, China Medicine Education Association

4.Committee member, Pancreatic Surgery Group, Surgical Branch, Chinese Medical Association

5.Expert member, Oncology Subcommittee, Chinese Medical Association

6.Committee member, Professional Committee on Precision Medicine, Chinese Medical Doctor Association

7.Standing committee, Pancreatic Cancer Expert Committee, CSCO

8.Chairman, Pancreatic Cancer Professional Committee, Tianjin Anti-Cancer Association

9.Vice chairman, Tianjin Youth Federation

10.Editorial Services: Executive Editor-in-Chief of Cancer Biology & Medicine

11.Ad hoc reviews: Cancer Res.; J. Biol. Chem.; Signal Transduct Target Ther.; Cancer Letters; Int. J. Cancer; PLoS ONE.

Grants

1.National Key R&D Plan: Combination of immune targets and nano engineering delivery systems for cancer therapy, SQ2021YFA1200099, Jihui hao (PI), 2022-2026.

2.National Science Fund for Distinguished Young Scholars: Oncology (Gastro-intestinal Cancer), No. 81525021, Jihui hao (PI), 2016-2020.

3.Key Program of National Natural Science Foundation of China: The mechanism of hypoxia-driven stellate cells interact with tumor cells regulation pancreatic cancer liver metastasis, No. 82030092, Jihui hao (PI), 2021-2025

4.National NSFC Projects of International Cooperation and Exchanges: Molecular Mechanism of ESE3 Expression Deletion Involved in Malignant Evolution and Immune Microscopic Remodeling of Pancreatic Cancer. No. 81720108028, Jihui hao (PI), 2018-2022.

5.Key Program of Prevention and Treatment of Chronic Diseases of Tianjin: To establish a clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabete and study the preventive effect of black raspberries on pancreatic cancer. No.17ZXMFSY00010, Jihui hao (PI), 2017-2020.

6.National Nature and Science Fund: Molecular Mechanism of CX3CL1/CX3CR1 Signaling Pathway in Regulation of Glucose Metabolism in Pancreatic Carcinoma. No. 31471340, Jihui hao (PI), 2015-2018.

7.National Nature and Science Fund: The mechanism of CD14+CD16+ monocyte subsets involved in fibrosis of pancreatic cancer. No. 81172355, Jihui hao (PI), 2012-2015.

8.National Nature and Science Fund: Crosstalk of HIF-1 and CX3CR1/CX3CL1 in the perineural invasion of pancreatic cancer. No. 30973490, Jihui hao (PI), 2010-2012.

9.Key Tianjin Nature and Science Fund: Clinical and Basic Research on Prevention and Treatment of Pancreatic Cancer. No. 12ZCDZSY16700, Jihui hao (PI), 2011-2015.








  No22.Qixiangtai Rd.,Heping Dist,Tianjin P.R. China

津ICP备05003123号 津教备0068号